|
Credit Facility (Details) (USD $)
|
1 Months Ended |
|---|---|
|
Jul. 31, 2012
|
|
| Credit Facility [Abstract] | |
| Maximum borrowing capacity | $ 50,000,000 |
| Current borrowing capacity | 15,000,000 |
| Current prime-based interest rate | 10.00% |
| Debt committed upon the approval of Lymphoseek on consistent terms | 20,000,000 |
| Amount potentially available on terms to be negotiated | $ 15,000,000 |
| X | ||||||||||
|
- Definition
Increase in the immediate borrowing capacity for which the terms have not been negotiated. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Increase for additional borrowings on the credit facility during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The effective interest rate at the end of the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|